Advertisement

Topics

German Biotech InflaRx Snags $100M in IPO

19:00 EST 8 Nov 2017 | BioSpace

The company announced the pricing of its initial public offering of 6,667,000 common shares at an initial public offering price of $15.00 per common share.

Original Article: German Biotech InflaRx Snags $100M in IPO

NEXT ARTICLE

More From BioPortfolio on "German Biotech InflaRx Snags $100M in IPO"

Advertisement
Quick Search
Advertisement
Advertisement